Proud to be Danish today and great day to be in Atlanta to witness Professor Møller present the results of the DanGer shock trial!

Despite being a small country we continue to deliver ground breaking science to the World.

Congratulations to the whole DanGer shock team.
CPR Trials & CIRL

Great job by Marta Figueiral, MD who presented significance of incidental cardiomyopathy genetic findings in complex rare diagnostic odyssey cases seen Mayo Clinic Center for Individualized Medicine American College of Cardiology

Beta-blockers in post-MI patients with LVEF greater or equal to 50% and obstructive CAD did not reduce death or MI in this open label registry based trial ⁦American College of Cardiology⁩

EMPACT-MI trial: Among patients hospitalized for acute myocardial infarction and at risk for heart failure, empagliflozin did not lead to a significantly lower risk of a first heart-failure hospitalization or death from any cause than placebo. nej.md/4cEb6EB

#ACC24

EMPACT-MI American College of Cardiology empagliflozin did not reduce time to heart failure (HF) hospitalization or total mortality in acute post MI. A trial that raises the question that acute HF is a different population and when these patients are promptly treated with standard therapy it works

Label restricted to ⬇️ in MI & Cor. Revascularization, 2 endpoints among 4-component MACE (PEP) that were significantly ⬇️.

Contrast this with empagliflozin label for HF which includes risk of CV death & HHF, despite only HHF ⬇️.

Why the inconsistency?

globenewswire.com/news-release/2…

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8

#PublicHealth

A huge honor 2 meet Dr Jill Biden Jill Biden today! Grateful for her compelling speech & commitment to #womenshealth

Cardiovascular disease is the #1 killer of 🚺! Need more research, implementation, 🚺 in trials, support for 🚺 in science
Duke University School of Medicine American Heart Association

Original Article: A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening (ECLIPSE study) nej.md/3v0J319

Science behind the Study: Cell-free DNA for Colorectal Cancer Screening nej.md/43noybx

Mayo Clinic in Rochester has once again been named the #1 hospital in the world by Newsweek in their 2024 rankings. Thank you to our exceptional staff who remain committed to our primary value of putting patients’ needs first. bit.ly/4bMahsG #WorldsBestHospitals

Happy to share our paper on CMR findings in biopsy negative graft dysfunction post OHT. LGE seen in about 1/2 of pts and assoc. w/ ⬆️ time since Tx, ⬆️ symptoms, ⬆️ hemo derangement, but no difference in outcomes on f/u.
onlinelibrary.wiley.com/doi/10.1002/eh…

Good morning from ⁦Mayo Clinic⁩ ⁦Mayo ClinicCV⁩ on our #Florida campus. Say, on 12/12-12/14, ⁦Naveen Pereira⁩ ⁦Iftikhar J. Kullo⁩ & I would like cardiologists, APPs, & trainees to join us in Puerto Rico for our next #Genetic #Cardiology CME course. Will be gr8!

Incredible devotion and commitment- also thank you MN State Patrol for facilitating this life saving heart #transplant

Congratulations to our Transplant Center for these 1,000 transplants and lives saved during 2023

74 Hearts 🫀
74 Lungs 🫁
*5 Heart/Lungs
141 Livers
12 Pancreases
298 Kidneys 🫘
401 BMT 🩸

Thanks to our teams and to our patients for making our job meaningful

🚨 Transplant Cardiologists!🚨

Mayo Clinic Florida is actively recruiting one AHFT cardiologist to join our amazing transplant team!

Apply here: …wp-saasfaprod1.fa.ocs.oraclecloud.com/hcmUI/Candidat…

Mayo Clinic embarks on a $5 billion project to revolutionize its flagship medical campus in #RochMN . Five new buildings will fuse traditional medical services with AI and digital tools, creating a 21st-century vision of clinical care. bit.ly/3uE2Wuk STAT

Local historic landmark designation: Pill Hill/Old South West Rochester - Sign the Petition! chng.it/58YbwgDd via Change.org

What a wonderful opportunity to discuss #AI for health equity & findings from the SPEC-AI Nigeria study as part of the Late Breaking Science Session at #AHA2023 ! #AI guided screening doubled the detection of cardiomyopathy cases compared to usual care!

My post-doc and NIGMS T32 scholar Min Wang extending our in vitro work Circulation Research ahajrnls.org/3MnGcob in-vivo to a pressure overload mouse model demonstrating CDCP1 KO markedly reduces fibrosis Duan Liu. Thanks to Mayo Clinic Center for Individualized Medicine for making this work possible

Researchers from Mayo Clinic and spinout company @AnumanaInc revealed in a new study the potential for ECG-AI models to uncover cardiovascular disease risks sooner than current risk equations and add a new dimension of clinical decision-making tools: bit.ly/3QQOG9X